A comparative clinical evaluation of chitraka haritaki avaleha and bharangyadi avaleha in the management of tamaka shwasa(bronchial asthama) - TSCHABA

Director IPGT RA GAU JAMNAGAR0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients of 2-10 years of age of either sex.
•Diagnosed cases of Tamaka Shwasa with atleast 2 episodes of asthma symptoms during the previous year.
•Patients on other drug therapy will be included only after completion of wash out period of 3 weeks.

•Children of age below 2 years and above 10 years.
•Evidence of active Concomitants Pulmonary Disease other than asthma.
•Evidence of requirement of intubations for asthma, or had been hospitalized for asthma within one month before.Had Unresolved Sinus Disease or an unresolved upper or lower respiratory tract infection within 2 weeks.
•Patients on active Corticosteroid Therapy Or More Than 4 short courses of oral corticosteroids within the year preceding the screening visit,or any oral corticosteroids in the preceding 4 weeks.Use of Astemizole,Nedocromil, Cromolyn,long acting beta agonists,Ketotifen,or Theophylline within 2 weeks before.
•Concomitant severe de-compensated systemic disease(cardiovascular,renal,hepatic,endocrine,hematological,neurological,immunological)

发起方

Director IPGT RA GAU JAMNAGAR